UBS Vitainvest (Switzerland) Manager Performance Evaluation

0P0000NRCC   157.20  0.00  0.00%   
The entity has a beta of -0.11, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning UBS Vitainvest are expected to decrease at a much lower rate. During the bear market, UBS Vitainvest is likely to outperform the market.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days UBS Vitainvest has generated negative risk-adjusted returns adding no value to fund investors. In spite of very healthy basic indicators, UBS Vitainvest is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
...more
  

UBS Vitainvest Relative Risk vs. Return Landscape

If you would invest  15,818  in UBS Vitainvest on October 5, 2024 and sell it today you would lose (98.00) from holding UBS Vitainvest or give up 0.62% of portfolio value over 90 days. UBS Vitainvest is generating negative expected returns and assumes 0.3718% volatility on return distribution over the 90 days horizon. Simply put, 3% of funds are less volatile than UBS, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon UBS Vitainvest is expected to under-perform the market. But the company apears to be less risky and when comparing its historical volatility, the company is 2.19 times less risky than the market. the firm trades about -0.03 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.04 of returns per unit of risk over similar time horizon.

UBS Vitainvest Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for UBS Vitainvest's investment risk. Standard deviation is the most common way to measure market volatility of funds, such as UBS Vitainvest , and traders can use it to determine the average amount a UBS Vitainvest's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0265

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns0P0000NRCC

Estimated Market Risk

 0.37
  actual daily
3
97% of assets are more volatile

Expected Return

 -0.01
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.03
  actual daily
0
Most of other assets perform better
Based on monthly moving average UBS Vitainvest is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of UBS Vitainvest by adding UBS Vitainvest to a well-diversified portfolio.

Things to note about UBS Vitainvest performance evaluation

Checking the ongoing alerts about UBS Vitainvest for important developments is a great way to find new opportunities for your next move. Fund alerts and notifications screener for UBS Vitainvest help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
UBS Vitainvest is not yet fully synchronised with the market data
UBS Vitainvest generated a negative expected return over the last 90 days
Evaluating UBS Vitainvest's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate UBS Vitainvest's fund performance include:
  • Analyzing UBS Vitainvest's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether UBS Vitainvest's stock is overvalued or undervalued compared to its peers.
  • Examining UBS Vitainvest's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating UBS Vitainvest's management team can have a significant impact on its success or failure. Reviewing the track record and experience of UBS Vitainvest's management team can help you assess the Fund's leadership.
  • Pay attention to analyst opinions and ratings of UBS Vitainvest's fund. These opinions can provide insight into UBS Vitainvest's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating UBS Vitainvest's fund performance is not an exact science, and many factors can impact UBS Vitainvest's fund market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments